Alveolus Bio
  • About Us
  • Science
  • Pipeline
  • Team
Select Page
Alveolus Bio’s Founder, Dr. Vivek Lal, to Present at BIO CEO & Investor Conference 

Alveolus Bio’s Founder, Dr. Vivek Lal, to Present at BIO CEO & Investor Conference 

by Alveolus Bio | Feb 11, 2022 | Company News

Birmingham, February 11, 2022 – Alveolus Bio announced today Dr. Vivek Lal, Founder & Chief Executive Officer, will be presenting at the upcoming 2022 BIO CEO & Investor Conference being held at the Marriott Marquis in NYC on February 14-15 and virtually...

Recent Posts

  • Alveolus Bio’s Founder, Dr. Vivek Lal, to Present at BIO CEO & Investor Conference 
  • Alveolus Bio to Present at Biotech Showcase 2022
  • Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD (2021)
  • Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia (2018)
  • The Airway Microbiome at Birth (2016)

Recent Comments

    1500 1st Ave N, Birmingham, AL 35203

    1 Broadway, Cambridge, MA 02142

    • Follow

    © Alveolus Bio Inc 2023

    Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. 

    ©Alveolus Bio Inc. 2023 | Please click here to access our Financial Conflict of Interest Policy